GNMX

Aevi Genomic Medicine, Inc.
GNMX

Overview Fund Activity
Delisted

GNMX was delisted on the 3rd of February, 2020.

Back to rankings

28 hedge funds and large institutions have $6.12M invested in Aevi Genomic Medicine, Inc. in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Holders
28
Holders Change
+3
Holders Change %
+12%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$382K
2
JC
2
JBF Capital
Colorado
$27K
3
UBS Group
3
UBS Group
Switzerland
$29K
4
LTFS
4
Ladenburg Thalmann Financial Services
Florida
$17K
5
VF
5
Virtu Financial
New York
$24K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$156K
2
Citadel Advisors
2
Citadel Advisors
Florida
$0
3
BC
3
Birchview Capital
Vermont
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
26
Concourse Financial Group Securities
Alabama
– – – –
Group One Trading
27
Group One Trading
Illinois
$0 1,758 – –
KTC
28
Kistler-Tiffany Companies
Pennsylvania
$0 690 – –
Simplex Trading
29
Simplex Trading
Illinois
$0 100 +100 New
RWB
30
RMR Wealth Builders
New Jersey
$0 250 +250 New
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$0 500 +500 New
1
2